What is the management protocol for anaphylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management Flow Chart for Anaphylaxis

Prompt administration of intramuscular epinephrine into the mid-outer thigh is the cornerstone of anaphylaxis management and should be given immediately upon recognition of anaphylaxis to reduce hospitalizations, morbidity, and mortality. 1

Initial Recognition and Assessment

  • Recognize anaphylaxis using validated clinical criteria:
    • Acute onset of illness with involvement of skin/mucosal tissue PLUS respiratory compromise OR reduced blood pressure
    • Two or more of: skin/mucosal involvement, respiratory compromise, reduced blood pressure, persistent GI symptoms
    • Reduced blood pressure after exposure to known allergen

Immediate Management

  1. Administer epinephrine immediately

    • Dose: 0.01 mg/kg of 1:1000 (1 mg/mL) solution, maximum 0.3 mg in children and 0.5 mg in adults 1, 2
    • Route: Intramuscular injection into the anterolateral thigh (vastus lateralis) 3
    • Frequency: Can repeat every 5-15 minutes if symptoms persist 2
    • Warning: Do NOT inject into buttocks, digits, hands, or feet due to risk of tissue necrosis 3
  2. Position patient appropriately

    • Place in recumbent position with elevated lower extremities 1
    • If breathing difficulty, allow to sit upright
  3. Establish and maintain airway

    • Consider endotracheal intubation or cricothyrotomy if necessary 1
  4. Administer oxygen

    • Give at 6-8 L/min 1
  5. Establish IV access

    • Insert large-bore IV catheter

Secondary Interventions

  1. Fluid resuscitation

    • Normal saline: 1-2 L for adults, 20 mL/kg bolus for children 1, 2
    • Repeat as needed based on response
  2. Adjunctive medications (after epinephrine)

    • H1 antihistamines: Diphenhydramine 1-2 mg/kg (max 50 mg) IV/IM 2
    • H2 antihistamines: Ranitidine 1 mg/kg IV (if available) 2
    • Corticosteroids: Prednisone 0.5-1 mg/kg orally or hydrocortisone 200 mg IV 1, 2
    • For bronchospasm: Nebulized albuterol 2.5-5 mg in 3 mL saline 2
  3. For refractory hypotension

    • Vasopressors: Dopamine 2-20 μg/kg/min, titrated to maintain systolic BP >90 mmHg 1
    • For patients on beta-blockers: Consider glucagon 1-5 mg IV over 5 minutes, followed by infusion of 5-15 μg/min 1

Management of Cardiopulmonary Arrest

  1. Begin CPR and ACLS protocols
  2. High-dose IV epinephrine
    • Adults: 1-3 mg (1:10,000) slowly IV over 3 minutes, then 4-10 μg/min infusion 1
    • Children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) every 3-5 minutes 1
  3. Aggressive volume expansion
  4. Consider atropine and transcutaneous pacing for asystole/PEA
  5. Continue prolonged resuscitation (more likely to be successful in anaphylaxis) 1

Observation and Discharge Planning

  1. Monitor for biphasic reactions

    • Observe for at least 4-6 hours after symptom resolution 2
    • Longer observation for severe reactions or those requiring multiple epinephrine doses
  2. Discharge planning

    • Prescribe epinephrine autoinjector (2 devices) 1, 2
    • Provide training on proper use
    • Create personalized anaphylaxis emergency action plan 2
    • Arrange follow-up with allergist-immunologist 1

Common Pitfalls to Avoid

  • Delayed epinephrine administration - Don't wait for complete symptom development
  • Incorrect injection site - The anterolateral thigh is the only appropriate site 3
  • Using antihistamines or steroids as first-line treatment - These are adjunctive only and do not replace epinephrine 2, 4
  • Insufficient monitoring - Biphasic reactions can occur hours after initial resolution
  • Failure to prescribe autoinjector - All patients with anaphylaxis should receive prescription and training
  • Insufficient dosing for obese patients - Standard autoinjectors may not reach muscle in very obese patients 4

Special Considerations

  • Pregnant patients: Administer epinephrine as in non-pregnant patients; benefits outweigh risks 2
  • Elderly or cardiac patients: Use epinephrine with caution but do not withhold; benefits outweigh risks 3
  • Beta-blocker use: May require glucagon for refractory hypotension 1
  • Infants <15 kg: Current lowest autoinjector dose (0.15 mg) may be high; careful dosing required 1

Remember that prompt recognition and immediate epinephrine administration are the most critical factors in preventing anaphylaxis-related mortality.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Allergic Reaction Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epinephrine in the Management of Anaphylaxis.

The journal of allergy and clinical immunology. In practice, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.